PI3Kα:3.5 nM (IC50)
PI3Kβ:25 nM (IC50)
PI3Kδ:5.2 nM (IC50)
PI3Kγ:15 nM (IC50)
mTOR:750 nM (IC50)
[1]. Daniel P Sutherlin, et al. Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase/mTOR inhibitors for the treatment of cancer. J Med Chem. 2010 Feb 11;53(3):1086-97.
陕西缔都医药有限责任公司
联系商家时请提及chemicalbook,有助于交易顺利完成!